The prodisc portfolio now includes four cervical and two lumbar devices. Five have been approved by the FDA, according to an Oct. 3 news release.
Centinel Spine’s Prodisc C Vivo and C SK cervical disc implants also reached a milestone last month, surpassing 2,500 cases in just one year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
